© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Kailera Therapeutics, Inc. (KLRA) shows an Average True Range (ATR) of N/A and an Enterprise Value of N/A. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into KLRA's underlying financial health and market activity.
| ATR | N/A |
| Enterprise Value | - |
| Avg Vol (3 Months) | - |
| Avg Vol (10 Days) | - |
Kailera Therapeutics, Inc. (KLRA) technical indicators as of August 25, 2026: the SMA 20 is N/A, SMA 50 at N/A, and SMA 200 at N/A. The RSI 14 value is N/A, suggesting its current momentum. These technical analysis signals help assess KLRA's price trends and potential future movements.
| SMA 20 | N/A |
| SMA 50 | N/A |
| SMA 200 | N/A |
| RSI 14 | N/A |
Kailera Therapeutics, Inc. (KLRA) stock performance overview as of August 25, 2026: The 52-week high is $24.19 (currently N/A below), and the 52-week low is $16.37 (currently N/A above). Over the past year, KLRA's performance is N/A, compared to the S&P 500's 2.57% change.
| 52-Week High | 24.19 |
| 52-Week High Chg | - |
| 52-Week Low | 16.37 |
| 52-Week Low Chg | - |
| S&P 500 52-Week Chg | 2.57% |
According to market data, Kailera Therapeutics, Inc. (KLRA) stock's recent performance metrics show that over the last month, KLRA is N/A, with a Year-to-Date (YTD) performance of N/A. Over the past year, the stock has seen a N/A change. These figures summarize KLRA's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 18.5 | 19.51 | 24.19 | 24.19 | 24.19 | 24.19 |
| Low | 16.37 | 16.37 | 16.37 | 16.37 | 16.37 | 16.37 |
| Performance | - | - | - | - | - | - |
According to current financial data, KLRA stock's P/E (TTM) ratio is -10.18, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.25. Key valuation ratios for KLRA, including P/S (N/A), P/B (1.64), and P/FCF (-15.92), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | KLRA | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -10.18 | -1.25 | -193.84 | 32.59 |
| P/S (TTM) | N/A | 3.71 | 466.36 | 5.98 |
| P/B (TTM) | 1.64 | 1.39 | 0.69 | 6.15 |
| P/FCF (TTM) | -15.92 | -4.42 | -651.18 | 34.82 |